ORMP
Oramed Pharmaceuticals Inc.
Price Chart
Latest Quote
$4.01
+0.13 (+3.35%)
Current Price
| Previous Close | $3.88 |
| Open | $3.89 |
| Day High | $4.08 |
| Day Low | $3.83 |
| Volume | 190,300 |
Stock Information
| Quarterly Dividend / Yield | $0.25 / 6.25% |
| Shares Outstanding | 40.93M |
| Quarterly Dividend Yield | 6.25% |
| Quarterly Dividend | $0.25 |
| Total Debt | $761K |
| Cash Equivalents | $65.84M |
| Net Income | $109.19M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $164.11M |
| P/E Ratio | 1.54 |
| EPS (TTM) | $2.60 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $99.03M |
| Income | $109.19M |
| Book/sh | $5.82 |
| Cash/sh | $1.61 |
Financial Ratios
| Quick Ratio | 6.28 |
| Current Ratio | 6.45 |
| Debt/Eq | 0.32 |
Returns & Margins
| ROA | -4.28% |
| ROE | 58.16% |
Ownership
| Insider Ownership | 17.83% |
| Institutional Ownership | 37.08% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -50.13 |
| P/B | 0.69 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $6.25 |
Technical Indicators
| SMA20 | $3.83 |
| SMA50 | $3.97 |
| SMA200 | $3.10 |
| RSI | 54.84 |
| ATR | 0.1786 |
| Shares Float | 28.57M |
| Short Float | 1.91% |
| Short Ratio | 3.37 |
| Volatility | 1.24 |
| Rel Volume | 0.99 |
Performance History
| Week | +3.62% |
| Month | -6.31% |
| Quarter | +14.90% |
| 6 Months | +41.96% |
| YTD | +47.82% |
| Year | +100.07% |
| 3 Years | +11.44% |
| 5 Years | -69.81% |
| 10 Years | -47.22% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $4.01 | 191,600 |
| 2026-06-18 | $3.88 | 149,700 |
| 2026-06-17 | $3.79 | 237,800 |
| 2026-06-16 | $3.77 | 122,300 |
| 2026-06-15 | $3.84 | 136,000 |
| 2026-06-12 | $3.87 | 112,800 |
| 2026-06-11 | $3.80 | 159,100 |
| 2026-06-10 | $3.70 | 173,700 |
| 2026-06-09 | $3.65 | 217,200 |
| 2026-06-08 | $3.64 | 135,000 |
| 2026-06-05 | $3.71 | 99,700 |
| 2026-06-04 | $3.81 | 167,000 |
| 2026-06-03 | $3.65 | 363,500 |
| 2026-06-02 | $3.60 | 395,200 |
| 2026-06-01 | $3.89 | 176,800 |
| 2026-05-29 | $3.97 | 122,000 |
| 2026-05-28 | $3.96 | 326,500 |
| 2026-05-27 | $3.98 | 133,800 |
| 2026-05-26 | $4.04 | 312,900 |
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
đ° Latest News
June 2026 Penny Stocks To Watch For Potential Growth
Simply Wall St. âĸ 2026-06-15T18:05:37Z
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
Simply Wall St. âĸ 2026-05-13T12:05:23Z
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors
Simply Wall St. âĸ 2026-04-14T18:06:00Z
Oramed: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-03-26T21:50:48ZCarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
Motley Fool âĸ 2026-02-03T15:20:49Z
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
Motley Fool âĸ 2026-02-03T15:06:20Z
3 Promising Penny Stocks With Market Caps Under $200M
Simply Wall St. âĸ 2026-01-14T12:05:23Z
Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch
Simply Wall St. âĸ 2025-12-16T12:05:14Z
There Are Some Holes In Oramed Pharmaceuticals' (NASDAQ:ORMP) Solid Earnings Release
Simply Wall St. âĸ 2025-11-21T11:27:08Z
Oramed: Q3 Earnings Snapshot
Associated Press Finance âĸ 2025-11-13T22:51:51Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,987,000 | $0 | - | - |
| Cost Of Revenue | $1,987,000 | $0 | - | - |
| Total Revenue | $2,000,000 | $0 | $1,340,000 | $2,703,000 |
| Operating Revenue | $2,000,000 | $0 | $1,340,000 | $2,703,000 |
| Expenses | ||||
| Interest Expense | $0 | $853,000 | $2,037,000 | $0 |
| Total Expenses | $17,088,000 | $12,781,000 | $17,109,000 | $43,301,000 |
| Other Income Expense | $88,645,000 | $-7,242,000 | $16,268,000 | $-630,000 |
| Other Non Operating Income Expenses | $958,000 | - | - | - |
| Net Non Operating Interest Income Expense | $1,767,000 | $4,103,000 | $4,589,000 | $3,564,000 |
| Total Other Finance Cost | $606,000 | $27,000 | $1,543,000 | $9,000 |
| Interest Expense Non Operating | $0 | $853,000 | $2,037,000 | $0 |
| Operating Expense | $15,101,000 | $12,781,000 | $17,109,000 | $43,301,000 |
| General And Administrative Expense | $8,720,000 | $6,457,000 | $8,425,000 | $13,811,000 |
| Selling And Marketing Expense | - | $0 | $-287,000 | $1,851,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $64,050,000 | $-19,060,000 | $5,525,000 | $-36,561,000 |
| Net Interest Income | $1,767,000 | $4,103,000 | $4,589,000 | $3,564,000 |
| Interest Income | $2,373,000 | $4,983,000 | $8,169,000 | $3,573,000 |
| Normalized Income | $-10,473,007 | $-13,338,820 | $-10,743,000 | $-36,063,300 |
| Net Income From Continuing And Discontinued Operation | $64,050,000 | $-19,060,000 | $5,525,000 | $-36,561,000 |
| Total Operating Income As Reported | $-15,088,000 | $-12,781,000 | $-15,769,000 | $-40,598,000 |
| Net Income Common Stockholders | $64,050,000 | $-19,060,000 | $5,525,000 | $-36,561,000 |
| Net Income | $64,050,000 | $-19,060,000 | $5,525,000 | $-36,561,000 |
| Net Income Including Noncontrolling Interests | $64,016,000 | $-19,103,000 | $5,088,000 | $-37,764,000 |
| Net Income Continuous Operations | $64,016,000 | $-19,103,000 | $5,088,000 | $-37,764,000 |
| Pretax Income | $75,324,000 | $-15,920,000 | $5,088,000 | $-37,664,000 |
| Interest Income Non Operating | $2,373,000 | $4,983,000 | $8,169,000 | $3,573,000 |
| Operating Income | $-15,088,000 | $-12,781,000 | $-15,769,000 | $-40,598,000 |
| Gross Profit | $13,000 | $0 | - | - |
| Per Share | ||||
| Diluted EPS | $1.50 | $-0.48 | $0.14 | $-0.94 |
| Basic EPS | $1.53 | $-0.48 | $0.14 | $-0.94 |
| Other | ||||
| Tax Effect Of Unusual Items | $13,163,993 | $-1,520,820 | $0 | $-132,300 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-12,242,000 | $-7,632,000 | $-8,947,000 | $-36,976,000 |
| Total Unusual Items | $87,687,000 | $-7,242,000 | $16,268,000 | $-630,000 |
| Total Unusual Items Excluding Goodwill | $87,687,000 | $-7,242,000 | $16,268,000 | $-630,000 |
| Reconciled Depreciation | $121,000 | $193,000 | $196,000 | $58,000 |
| EBITDA (Bullshit earnings) | $75,445,000 | $-14,874,000 | $7,321,000 | $-37,606,000 |
| EBIT | $75,324,000 | $-15,067,000 | $7,125,000 | $-37,664,000 |
| Diluted Average Shares | $42,418,644 | $40,850,446 | $40,566,901 | $38,997,649 |
| Basic Average Shares | $41,402,997 | $40,850,446 | $40,315,068 | $38,997,649 |
| Diluted NI Availto Com Stockholders | $64,050,000 | $-19,060,000 | $5,525,000 | $-36,561,000 |
| Minority Interests | $34,000 | $43,000 | $437,000 | $1,203,000 |
| Tax Provision | $11,308,000 | $3,183,000 | $0 | $100,000 |
| Gain On Sale Of Security | $87,687,000 | $-7,242,000 | $16,268,000 | $-630,000 |
| Research And Development | $6,381,000 | $6,324,000 | $8,971,000 | $27,639,000 |
| Selling General And Administration | $8,720,000 | $6,457,000 | $8,138,000 | $15,662,000 |
| Other Gand A | $8,720,000 | $6,457,000 | $8,425,000 | $13,811,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $199,744,000 | $146,265,000 | $163,821,000 | $151,812,000 |
| Total Assets | $230,864,000 | $155,278,000 | $220,551,000 | $161,642,000 |
| Total Non Current Assets | $97,593,000 | $12,057,000 | $57,967,000 | $4,533,000 |
| Non Current Prepaid Assets | $2,000 | $2,000 | $7,000 | $7,000 |
| Non Current Note Receivables | $553,000 | $0 | - | - |
| Investmentin Financial Assets | $22,114,000 | $10,911,000 | $54,926,000 | $2,700,000 |
| Current Assets | $133,271,000 | $143,221,000 | $162,584,000 | $157,109,000 |
| Other Current Assets | $2,741,000 | $1,291,000 | $537,000 | $1,389,000 |
| Receivables | $4,636,000 | $0 | - | - |
| Notes Receivable | $4,636,000 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $125,894,000 | $141,930,000 | $162,047,000 | $155,720,000 |
| Cash And Cash Equivalents | $45,947,000 | $54,420,000 | $9,055,000 | $40,464,000 |
| Financial Assets | - | $0 | $1,440,000 | $0 |
| Cash Financial | - | - | $9,055,000 | $40,464,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $825,000 | $372,000 | $51,622,000 | $894,000 |
| Long Term Debt And Capital Lease Obligation | $540,000 | $156,000 | $342,000 | $647,000 |
| Current Debt And Capital Lease Obligation | $285,000 | $216,000 | $51,280,000 | $247,000 |
| Net Debt | - | - | $41,958,000 | - |
| Current Debt | - | - | $51,013,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $31,120,000 | $9,931,000 | $57,658,000 | $10,486,000 |
| Total Non Current Liabilities Net Minority Interest | $12,034,000 | $4,246,000 | $4,444,000 | $4,740,000 |
| Tradeand Other Payables Non Current | $275,000 | - | - | - |
| Non Current Deferred Liabilities | $11,180,000 | $4,000,000 | $4,011,000 | $4,011,000 |
| Non Current Deferred Taxes Liabilities | $7,911,000 | $0 | $11,000 | $11,000 |
| Current Liabilities | $19,086,000 | $5,685,000 | $53,214,000 | $5,746,000 |
| Current Deferred Liabilities | $1,353,000 | $0 | $0 | $1,340,000 |
| Payables And Accrued Expenses | $17,448,000 | $5,469,000 | $1,934,000 | $4,159,000 |
| Payables | $14,976,000 | $4,322,000 | $876,000 | $2,176,000 |
| Dividends Payable | $10,595,000 | $0 | - | - |
| Total Tax Payable | $3,286,000 | $3,204,000 | $0 | - |
| Income Tax Payable | $3,286,000 | $3,204,000 | $0 | - |
| Accounts Payable | $443,000 | $789,000 | $551,000 | $2,175,000 |
| Other Non Current Liabilities | - | $60,000 | $63,000 | $61,000 |
| Equity | ||||
| Common Stock Equity | $199,744,000 | $146,265,000 | $163,821,000 | $151,812,000 |
| Total Equity Gross Minority Interest | $199,744,000 | $145,347,000 | $162,893,000 | $151,156,000 |
| Stockholders Equity | $199,744,000 | $146,265,000 | $163,821,000 | $151,812,000 |
| Retained Earnings | $-123,436,000 | $-176,616,000 | $-157,556,000 | $-163,081,000 |
| Long Term Equity Investment | $71,623,000 | $0 | - | - |
| Other | ||||
| Ordinary Shares Number | $39,275,006 | $39,919,545 | $40,338,979 | $39,563,888 |
| Share Issued | $39,275,006 | $39,919,545 | $40,338,979 | $39,563,888 |
| Tangible Book Value | $199,744,000 | $146,265,000 | $163,821,000 | $151,812,000 |
| Invested Capital | $199,744,000 | $146,265,000 | $214,834,000 | $151,812,000 |
| Working Capital | $114,185,000 | $137,536,000 | $109,370,000 | $151,363,000 |
| Capital Lease Obligations | $825,000 | $372,000 | $609,000 | $894,000 |
| Total Capitalization | $199,744,000 | $146,265,000 | $163,821,000 | $151,812,000 |
| Minority Interest | $0 | $-918,000 | $-928,000 | $-656,000 |
| Additional Paid In Capital | $322,708,000 | $322,401,000 | $320,892,000 | $314,417,000 |
| Capital Stock | $472,000 | $480,000 | $485,000 | $476,000 |
| Common Stock | $472,000 | $480,000 | $485,000 | $476,000 |
| Employee Benefits | $39,000 | $30,000 | $28,000 | $21,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $39,000 | $30,000 | $28,000 | $21,000 |
| Non Current Deferred Revenue | $3,269,000 | $4,000,000 | $4,000,000 | $4,000,000 |
| Long Term Capital Lease Obligation | $540,000 | $156,000 | $342,000 | $647,000 |
| Current Deferred Revenue | $1,353,000 | $0 | $0 | $1,340,000 |
| Current Capital Lease Obligation | $285,000 | $216,000 | $267,000 | $247,000 |
| Current Accrued Expenses | $2,472,000 | $1,147,000 | $1,058,000 | $1,983,000 |
| Dueto Related Parties Current | $652,000 | $329,000 | $325,000 | $1,000 |
| Defined Pension Benefit | $44,000 | $32,000 | $27,000 | $24,000 |
| Investments And Advances | $93,737,000 | $10,911,000 | $54,926,000 | $2,700,000 |
| Available For Sale Securities | $13,743,000 | $10,911,000 | $54,559,000 | $2,700,000 |
| Trading Securities | $8,371,000 | $0 | $367,000 | - |
| Investmentsin Associatesat Cost | $71,623,000 | $0 | - | - |
| Investment Properties | $1,921,000 | $0 | - | - |
| Net PPE | $1,336,000 | $1,112,000 | $1,567,000 | $1,802,000 |
| Gross PPE | $1,336,000 | $1,112,000 | $1,567,000 | $1,802,000 |
| Other Properties | $1,336,000 | $1,112,000 | $1,567,000 | $1,802,000 |
| Other Short Term Investments | $79,947,000 | $87,510,000 | $152,992,000 | $115,256,000 |
| Line Of Credit | - | $0 | $51,013,000 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Other Investments | - | - | $51,035,000 | $0 |
| Held To Maturity Securities | - | - | - | $0 |
| Machinery Furniture Equipment | - | - | - | $7,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-11,078,000 | $-8,430,000 | $-10,549,000 | $-28,414,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,145,000 | $-8,412,000 | $-10,295,000 | $-27,918,000 |
| Cash Flow From Continuing Operating Activities | $-9,145,000 | $-8,412,000 | $-10,295,000 | $-27,918,000 |
| Operating Gains Losses | $818,000 | $-2,705,000 | $-2,175,000 | $-1,563,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,933,000 | $-18,000 | $-254,000 | $-496,000 |
| Investing Cash Flow | $5,443,000 | $105,817,000 | $-73,038,000 | $30,211,000 |
| Cash Flow From Continuing Investing Activities | $5,443,000 | $105,817,000 | $-73,038,000 | $30,211,000 |
| Net Other Investing Changes | $6,251,000 | $-65,000 | - | $2,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-4,741,000 | $-2,484,000 | $0 | - |
| Financing Cash Flow | $-4,741,000 | $-52,036,000 | $51,978,000 | $10,779,000 |
| Cash Flow From Continuing Financing Activities | $-4,741,000 | $-52,036,000 | $51,978,000 | $10,779,000 |
| Net Common Stock Issuance | $-4,741,000 | $-2,484,000 | $2,428,000 | $11,500,000 |
| Issuance Of Capital Stock | - | $0 | $2,428,000 | $11,500,000 |
| Net Other Financing Charges | - | $-2,000 | - | $-783,000 |
| Common Stock Issuance | - | $0 | $2,428,000 | $11,500,000 |
| Other | ||||
| Repayment Of Debt | $0 | $-49,550,000 | $-50,000,000 | $0 |
| Interest Paid Supplemental Data | $0 | $2,316,000 | $574,000 | $0 |
| End Cash Position | $45,947,000 | $54,420,000 | $9,055,000 | $40,464,000 |
| Beginning Cash Position | $54,420,000 | $9,055,000 | $40,464,000 | $27,456,000 |
| Effect Of Exchange Rate Changes | $-30,000 | $-4,000 | $-54,000 | $-64,000 |
| Changes In Cash | $-8,443,000 | $45,369,000 | $-31,355,000 | $13,072,000 |
| Common Stock Payments | $-4,741,000 | $-2,484,000 | $0 | - |
| Net Issuance Payments Of Debt | $0 | $-49,550,000 | $49,550,000 | $0 |
| Net Short Term Debt Issuance | $0 | $-49,550,000 | $-50,000,000 | $0 |
| Short Term Debt Payments | $0 | $-49,550,000 | $-50,000,000 | $0 |
| Net Investment Purchase And Sale | $8,375,000 | $105,900,000 | $-72,784,000 | $30,681,000 |
| Sale Of Investment | $96,881,000 | $161,657,000 | $118,135,000 | $185,086,000 |
| Purchase Of Investment | $-88,506,000 | $-55,757,000 | $-190,919,000 | $-154,405,000 |
| Net Business Purchase And Sale | $-7,250,000 | $0 | - | - |
| Purchase Of Business | $-7,250,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-1,933,000 | $-18,000 | $-254,000 | $-472,000 |
| Purchase Of PPE | $-1,933,000 | $-18,000 | $-254,000 | $-496,000 |
| Change In Working Capital | $-1,907,000 | $3,200,000 | $-2,696,000 | $-943,000 |
| Change In Other Working Capital | $-1,979,000 | $45,000 | $-1,325,000 | $-797,000 |
| Change In Other Current Liabilities | $-60,000 | $-14,000 | $2,000 | $-38,000 |
| Change In Payables And Accrued Expense | $1,130,000 | $3,525,000 | $-2,225,000 | $-376,000 |
| Change In Payable | $1,130,000 | $3,525,000 | $-2,225,000 | $-376,000 |
| Change In Account Payable | $1,130,000 | $3,525,000 | $-2,225,000 | $-376,000 |
| Change In Prepaid Assets | $-998,000 | $-356,000 | $852,000 | $268,000 |
| Stock Based Compensation | $5,992,000 | $4,053,000 | $4,212,000 | $11,509,000 |
| Unrealized Gain Loss On Investment Securities | $-86,096,000 | $7,413,000 | $-16,392,000 | $763,000 |
| Deferred Tax | $7,911,000 | $0 | - | - |
| Deferred Income Tax | $7,911,000 | $0 | - | - |
| Depreciation Amortization Depletion | $121,000 | $193,000 | $196,000 | $58,000 |
| Depreciation And Amortization | $121,000 | $193,000 | $196,000 | $58,000 |
| Depreciation | $121,000 | $193,000 | $196,000 | $58,000 |
| Pension And Employee Benefit Expense | $-12,000 | $-5,000 | $-3,000 | $0 |
| Net Foreign Currency Exchange Gain Loss | $830,000 | $-2,700,000 | $-2,172,000 | $-1,550,000 |
| Net Income From Continuing Operations | $64,016,000 | $-19,103,000 | $5,088,000 | $-37,764,000 |
| Issuance Of Debt | - | $0 | $99,550,000 | $0 |
| Net Long Term Debt Issuance | - | $0 | $99,550,000 | $0 |
| Long Term Debt Issuance | - | $0 | $99,550,000 | $0 |
| Other Non Cash Items | - | $-1,463,000 | $1,472,000 | $22,000 |
| Income Tax Paid Supplemental Data | - | - | $0 | $100,000 |
| Proceeds From Stock Option Exercised | - | - | $0 | $62,000 |
| Long Term Debt Payments | - | - | $-50,000,000 | $0 |
| Sale Of PPE | - | - | $0 | $24,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $-13,000 |
Fetched: 2026-06-22